Found: 2
Select item for more details and to access through your institution.
HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results of a Multicenter, Retrospective Cohort Study.
- Published in:
- Cancers, 2022, v. 14, n. 20, p. 4981, doi. 10.3390/cancers14204981
- By:
- Publication type:
- Article
Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1362641
- By:
- Publication type:
- Article